199 related articles for article (PubMed ID: 29713059)
1. Inactivation of the serine protease HTRA1 inhibits tumor growth by deregulating angiogenesis.
Klose R; Adam MG; Weis EM; Moll I; Wüstehube-Lausch J; Tetzlaff F; Oka C; Ehrmann M; Fischer A
Oncogene; 2018 Aug; 37(31):4260-4272. PubMed ID: 29713059
[TBL] [Abstract][Full Text] [Related]
2. Endothelial Jagged1 Antagonizes Dll4/Notch Signaling in Decidual Angiogenesis during Early Mouse Pregnancy.
Marchetto NM; Begum S; Wu T; O'Besso V; Yarborough CC; Valero-Pacheco N; Beaulieu AM; Kitajewski JK; Shawber CJ; Douglas NC
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899448
[TBL] [Abstract][Full Text] [Related]
3. MPDZ promotes DLL4-induced Notch signaling during angiogenesis.
Tetzlaff F; Adam MG; Feldner A; Moll I; Menuchin A; Rodriguez-Vita J; Sprinzak D; Fischer A
Elife; 2018 Apr; 7():. PubMed ID: 29620522
[TBL] [Abstract][Full Text] [Related]
4. Galectin-3 acts as an angiogenic switch to induce tumor angiogenesis via Jagged-1/Notch activation.
Dos Santos SN; Sheldon H; Pereira JX; Paluch C; Bridges EM; El-Cheikh MC; Harris AL; Bernardes ES
Oncotarget; 2017 Jul; 8(30):49484-49501. PubMed ID: 28533486
[TBL] [Abstract][Full Text] [Related]
5. Adrenergic signaling promotes angiogenesis through endothelial cell-tumor cell crosstalk.
Chen H; Liu D; Yang Z; Sun L; Deng Q; Yang S; Qian L; Guo L; Yu M; Hu M; Shi M; Guo N
Endocr Relat Cancer; 2014 Oct; 21(5):783-95. PubMed ID: 25179535
[TBL] [Abstract][Full Text] [Related]
6. Oridonin inhibits tumor growth and metastasis through anti-angiogenesis by blocking the Notch signaling.
Dong Y; Zhang T; Li J; Deng H; Song Y; Zhai D; Peng Y; Lu X; Liu M; Zhao Y; Yi Z
PLoS One; 2014; 9(12):e113830. PubMed ID: 25485753
[TBL] [Abstract][Full Text] [Related]
7. Extracellular vesicle-carried Jagged-1 inhibits HUVEC sprouting in a 3D microenvironment.
Tan E; Asada HH; Ge R
Angiogenesis; 2018 Aug; 21(3):571-580. PubMed ID: 29541959
[TBL] [Abstract][Full Text] [Related]
8. Integrin cytoplasmic domain-associated protein-1 attenuates sprouting angiogenesis.
Brütsch R; Liebler SS; Wüstehube J; Bartol A; Herberich SE; Adam MG; Telzerow A; Augustin HG; Fischer A
Circ Res; 2010 Sep; 107(5):592-601. PubMed ID: 20616313
[TBL] [Abstract][Full Text] [Related]
9. Delta-like 4/Notch signaling promotes Apc
Badenes M; Trindade A; Pissarra H; Lopes-da-Costa L; Duarte A
BMC Cancer; 2017 Jan; 17(1):50. PubMed ID: 28086833
[TBL] [Abstract][Full Text] [Related]
10. NOTCH decoys that selectively block DLL/NOTCH or JAG/NOTCH disrupt angiogenesis by unique mechanisms to inhibit tumor growth.
Kangsamaksin T; Murtomaki A; Kofler NM; Cuervo H; Chaudhri RA; Tattersall IW; Rosenstiel PE; Shawber CJ; Kitajewski J
Cancer Discov; 2015 Feb; 5(2):182-97. PubMed ID: 25387766
[TBL] [Abstract][Full Text] [Related]
11. Loss of the serine protease HTRA1 impairs smooth muscle cells maturation.
Klose R; Prinz A; Tetzlaff F; Weis EM; Moll I; Rodriguez-Vita J; Oka C; Korff T; Fischer A
Sci Rep; 2019 Dec; 9(1):18224. PubMed ID: 31796853
[TBL] [Abstract][Full Text] [Related]
12. Role of Delta-like 4 in Jagged1-induced tumour angiogenesis and tumour growth.
Oon CE; Bridges E; Sheldon H; Sainson RCA; Jubb A; Turley H; Leek R; Buffa F; Harris AL; Li JL
Oncotarget; 2017 Jun; 8(25):40115-40131. PubMed ID: 28445154
[TBL] [Abstract][Full Text] [Related]
13. Jagged mediates differences in normal and tumor angiogenesis by affecting tip-stalk fate decision.
Boareto M; Jolly MK; Ben-Jacob E; Onuchic JN
Proc Natl Acad Sci U S A; 2015 Jul; 112(29):E3836-44. PubMed ID: 26153421
[TBL] [Abstract][Full Text] [Related]
14. Synaptojanin-2 binding protein stabilizes the Notch ligands DLL1 and DLL4 and inhibits sprouting angiogenesis.
Adam MG; Berger C; Feldner A; Yang WJ; Wüstehube-Lausch J; Herberich SE; Pinder M; Gesierich S; Hammes HP; Augustin HG; Fischer A
Circ Res; 2013 Nov; 113(11):1206-18. PubMed ID: 24025447
[TBL] [Abstract][Full Text] [Related]
15. Endothelial Jagged1 promotes solid tumor growth through both pro-angiogenic and angiocrine functions.
Pedrosa AR; Trindade A; Carvalho C; Graça J; Carvalho S; Peleteiro MC; Adams RH; Duarte A
Oncotarget; 2015 Sep; 6(27):24404-23. PubMed ID: 26213336
[TBL] [Abstract][Full Text] [Related]
16. SUMOylation Negatively Regulates Angiogenesis by Targeting Endothelial NOTCH Signaling.
Zhu X; Ding S; Qiu C; Shi Y; Song L; Wang Y; Wang Y; Li J; Wang Y; Sun Y; Qin L; Chen J; Simons M; Min W; Yu L
Circ Res; 2017 Sep; 121(6):636-649. PubMed ID: 28760777
[TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
18. Notch pathway targets proangiogenic regulator Sox17 to restrict angiogenesis.
Lee SH; Lee S; Yang H; Song S; Kim K; Saunders TL; Yoon JK; Koh GY; Kim I
Circ Res; 2014 Jul; 115(2):215-26. PubMed ID: 24755984
[TBL] [Abstract][Full Text] [Related]
19. Elevated Flk1 (vascular endothelial growth factor receptor 2) signaling mediates enhanced angiogenesis in beta3-integrin-deficient mice.
Reynolds AR; Reynolds LE; Nagel TE; Lively JC; Robinson SD; Hicklin DJ; Bodary SC; Hodivala-Dilke KM
Cancer Res; 2004 Dec; 64(23):8643-50. PubMed ID: 15574772
[TBL] [Abstract][Full Text] [Related]
20. Endothelial-specific Notch blockade inhibits vascular function and tumor growth through an eNOS-dependent mechanism.
Patenaude A; Fuller M; Chang L; Wong F; Paliouras G; Shaw R; Kyle AH; Umlandt P; Baker JH; Diaz E; Tong J; Minchinton AI; Karsan A
Cancer Res; 2014 May; 74(9):2402-11. PubMed ID: 24599126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
